Real-world prognostic model for malignant pleural mesothelioma.

被引：0
|
作者：
Nasser, Abdullah
Baird, Andrew
Saint-Pierre, Mathieu D.
Laurie, Scott A.
Wheatley-Price, Paul
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Ottawa Hosp, Dept Med, Div Respirol, Gen Campus, Ottawa, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
[4] Univ Ottawa, Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e20562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20562
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MicroRNA prognostic signature in malignant pleural mesothelioma.
    Grossi, Francesco
    Truini, Anna
    Nadal, Ernest
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Biello, Federica
    Coco, Simona
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Alama, Angela
    Beer, David G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Novel prognostic markers for epithelioid malignant pleural mesothelioma.
    Bruno, Rossella
    Poma, Anello Marcello
    Ad, Greta
    Giannini, Riccardo
    Puppo, Gianfranco
    Melfi, Franca
    Lucchi, Marco
    Mussi, Alfredo
    Falcone, Alfredo
    Chella, Antonio
    Fontanini, Gabriella
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Real-world outcomes of pembrolizumab in peritoneal mesothelioma.
    Marmarelis, Melina Elpi
    Wang, Xiao
    Roshkovan, Leonid
    Walker, Suzanne
    McNulty, Sally
    Ciunci, Christine Agnes
    Muira, John
    Katz, Sharyn, I
    Cengel, Keith A.
    Karakousis, Giorgos
    Langer, Corey J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Real-world treatment for malignant pleural mesothelioma: the Belgian experience
    Rosskamp, M.
    Van Damme, N.
    De Schutter, H.
    Slabbaert, M.
    Henau, K.
    Praet, M.
    Nackaerts, K.
    Van Meerbeeck, J. P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S177 - S178
  • [5] The prognostic value of FDG-PET imaging in malignant pleural mesothelioma.
    Bénard, F
    Alavi, A
    Sterman, D
    Shnier, D
    Smith, RJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 81P - 81P
  • [6] Prognostic value of tumor infiltrating lymphocytes in epithelioid malignant pleural mesothelioma.
    Adashek, Michael
    Chan, Abigail Sy
    Heath, Johnathan
    Fanaroff, Rachel
    Kallen, Michael E.
    Friedberg, Joseph S.
    Culligan, Melissa
    Khashab, Tamara
    Miller, Kenneth David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Treatment of malignant pleural mesothelioma. Surgical options
    Huwer H.
    Bücker A.
    [J]. Der Pneumologe, 2010, 7 (1): : 28 - 35
  • [8] Dysphagia as a presenting symptom of malignant pleural mesothelioma.
    Mendoza, H
    Huarte, MP
    Iglesias, R
    Lozano, A
    Jimenez, C
    Aizcorbe, M
    Almudevar, E
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (03) : 217 - 220
  • [9] The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma
    Wheatley-Price, Paul
    Moore, Sara
    Lee, Christopher W.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (04):
  • [10] Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
    Cedres, Susana
    Assaf, Juan-David
    Iranzo, Patricia
    Callejo, Ana
    Pardo, Nuria
    Navarro, Alejandro
    Martinez-Marti, Alex
    Marmolejo, David
    Rezqallah, Alejandra
    Carbonell, Caterina
    Frigola, Joan
    Amat, Ramon
    Pedrola, Anna
    Dienstmann, Rodrigo
    Felip, Enriqueta
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
12345